Sangamo TherapeuticsSGMO
那斯達克 · USD
0.26
-0.01
(-4.66%)
收盤 04/22 03:59 (UTC+8)
盤後
0.26
0.26
(+1.36%)
04/22 03:59 (UTC+8)
Sangamo TherapeuticsSGMO
0.26
-0.01
(-4.66%)
財務數據
損益表
- 0.09
- 0.02
- 0.00
- 0.00
- 0.49
- 0.08
- 0.06
- 0.18
- 0.01
- 0.14
- 37.50
- -78.27
- -76.44
- -25.99
- 13779.78
- -84.72
- -14.75
- 184.39
- -96.83
- 2348.88
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 14,228 | 581 | 18,306 | 6,437 | 7,551 | 49,412 | 356 | 481 | 2,042 | 9,398 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 14,228 | 581 | 18,306 | 6,437 | 7,551 | 49,412 | 356 | 481 | 2,042 | 9,398 |
營業費用 | 52,431 | 36,134 | 36,161 | - | 33,541 | - | - | 52,007 | 64,101 | 115,806 |
研發費用 | 31,438 | 28,142 | 27,084 | 26,006 | 23,675 | 27,732 | 24,223 | 35,891 | 50,706 | 57,089 |
推銷及管理費用 | 7,758 | 7,992 | 9,077 | 10,059 | 9,866 | 11,049 | 12,045 | 11,767 | 13,099 | 13,918 |
非經常性項目費用 | 13,235 | - | - | - | - | - | 1,172 | 4,349 | 296 | 44,799 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -38,203 | -35,553 | -17,855 | -29,628 | -25,990 | 10,631 | -37,084 | -51,526 | -62,059 | -106,408 |
其他收入及費用 | 231 | 462 | -2,104 | -850 | 2,167 | 129 | 1,030 | 2,535 | 1,492 | 3,515 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -37,972 | -35,091 | -19,959 | -30,478 | -23,823 | 10,760 | -36,054 | -48,991 | -60,567 | -102,893 |
所得稅 | -553 | -161 | 27 | 119 | -427 | 88 | 74 | 98 | -272 | 1,270 |
稅後純益 | -37,419 | -34,930 | -19,986 | -30,597 | -23,396 | 10,672 | -36,128 | -49,089 | -60,295 | -104,163 |
基本每股稅後盈餘(元) | -0.11 | -0.11 | -0.08 | -0.14 | -0.11 | 0.05 | -0.18 | -0.27 | - | -0.59 |
稀釋每股稅後盈餘(元) | -0.11 | -0.11 | -0.08 | -0.14 | -0.12 | 0.07 | -0.17 | -0.27 | -0.34 | -0.60 |
基本平均股數(千股) | 337732.00 | 304268.00 | 256950.00 | 220269.00 | 210185.00 | 208345.00 | 203946.00 | 180342.00 | - | 177171.00 |
稀釋平均股數(千股) | 337732.00 | 304268.00 | 256950.00 | 220269.00 | 210185.00 | 214325.00 | 203946.00 | 180342.00 | - | 177171.00 |
還原基本每股稅後盈餘(元) | -0.11 | -0.11 | -0.08 | -0.14 | -0.11 | 0.05 | -0.18 | -0.27 | - | -0.59 |
還原稀釋每股稅後盈餘(元) | -0.11 | -0.11 | -0.08 | -0.14 | -0.12 | 0.07 | -0.17 | -0.27 | -0.34 | -0.60 |
還原基本平均股數(千股) | 337,732 | 304,268 | 256,950 | 220,269 | 210,185 | 208,345 | 203,946 | 180,342 | - | 177,171 |
還原稀釋平均股數(千股) | 337,732 | 304,268 | 256,950 | 220,269 | 210,185 | 214,325 | 203,946 | 180,342 | - | 177,171 |
EBITDA(千元) | -36,089 | -33,193 | -18,062 | -28,554 | -21,688 | 12,887 | -33,481 | -46,738 | -57,856 | -95,639 |